GWM
TEVA icon

Gilpin Wealth Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Gilpin Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$13.9K Buy
351
+246
+234% +$8.8K 0.01% 310
2026
Q2 		$3.56K Hold
105
– – ﹤0.01% 394
2026
Q1 		$3.16K Buy
+105
New +$3.38K ﹤0.01% 391

Other funds holding TEVA

WWM
Whalen Wealth Management Las Vegas, Nevada $234M AUM 28.06% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
CAM
Cacti Asset Management Atlanta, Georgia $1.89B AUM 58.55% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $569M AUM 15.41% 1-Year Est. Return
VEM
Vann Equity Management Plano, Texas $168M AUM
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
BAM
Byrne Asset Management Kingston, New Jersey $179M AUM 29.67% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return
AAG
Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return

Gilpin Wealth Management's TEVA Position: Q3 2026 in Review

Gilpin Wealth Management increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 234% in Q3 2026, buying an estimated $8.8K and bringing the position to 351 shares worth $13.9K. The position accounts for 0.01% of the portfolio, ranked #310.

Gilpin Wealth Management first reported a position in TEVA in Q1 2026 and has held it in 3 quarters since. 10 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

  • Gilpin Wealth Management held 351 shares of Teva Pharmaceutical Industries Limited worth $13.9K as of Q3 2026.
  • Gilpin Wealth Management bought 246 Teva Pharmaceutical Industries Limited shares in Q3 2026, an estimated $8.8K.
  • Teva Pharmaceutical Industries Limited made up 0.01% of Gilpin Wealth Management's portfolio in Q3 2026, its #310 holding.
  • Gilpin Wealth Management first reported a position in Teva Pharmaceutical Industries Limited in Q1 2026 and has held it in 3 quarters since.
  • 10 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2026.

Based on Gilpin Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.